OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced on [date] that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility comprises a $25 million term loan and a $10 million revolving credit facility, which was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
The new credit facility strengthens OptimizeRx's balance sheet and provides additional liquidity to support the company's growth initiatives. According to the announcement, the funds are expected to be used for general corporate purposes, including potential strategic acquisitions and investments in expanding its technology platform.
OptimizeRx is a leading healthcare technology company that redefines how life science brands connect with patients and healthcare providers. Its platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, the company empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
The company's commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world's leading pharmaceutical and life sciences companies to transform the healthcare landscape.
This financing comes at a time when the digital health sector is experiencing rapid growth, with increasing demand for targeted patient engagement solutions. The additional capital positions OptimizeRx to capitalize on market opportunities and further develop its AI-driven platform.
For more information about OptimizeRx, visit www.optimizerx.com.
The full announcement can be viewed at https://ibn.fm/G0Fj3.
